Another study suggested that FGF21 had sensitivity and specificity of 72.6 and 85.1% for diagnosis of NAFLD as well as sensitivity and specificity of 53.7 and 71.9% for diagnosis of NASH (83). The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatohepatitis.